Novo Nordisk Stock Climbs as Analyst Flags Potential for More Wegovy Pill Sales

Novo Nordisk Stock Climbs as Analyst Flags Potential for More Wegovy Pill Sales

Novo Nordisk’s (NVO) shares in Copenhagen closed roughly 5% higher on Friday. This came after Nordea (NRDBY) went bullish on the Danish drugmaker, upgrading its NVO rating from Hold to Buy. The financial services firm noted that it sees the potential for sales of the Wegovy pill to top estimates.TipRanks’ Prime Week Sale – 70% Off Novo Nordisk Makes Waves with Wegovy The Danish company launched the pill — the oral version of its blockbuster Wego…